
James Alexander Booth
- Researcher; PhD
- +47 230 13 910
Contact information
James Booth PhD
Department of Microbiology
Oslo University Hospital Rikshospitalet
PO Box 4950
Nydalen NO-0424
Oslo, Norway
jamboo@ous-hf.no
james.booth@ntnu.no
Publications 2026
Antibacterial peptidomimetics via fragment display on small-molecule scaffolds
RSC Med Chem, 17 (4), 1989-2001 (in press)
DOI 10.1039/d5md00916b, PubMed 41782641
Antimicrobial Peptides Based on the TisB Toxin: Toward Enhanced Activity and Synergy with Antibiotics
ACS Omega, 11 (26), 38837-38847
DOI 10.1021/acsomega.6c02137, PubMed 42428866
The RecBCD complex interacts directly with the DNA sliding clamp in Escherichia coli
Nucleic Acids Res, 54 (11)
DOI 10.1093/nar/gkag570, PubMed 42273914
Exploring the genetic landscape of ciprofloxacin-induced DNA supercompaction in Escherichia coli
Nucleic Acids Res, 54 (12)
DOI 10.1093/nar/gkag573, PubMed 42328795
Publications 2025
Rational Design of Antimicrobial Peptides Based on Bacterial Type‑I Toxins AapA1, IbsC, and Fst1
ACS Omega, 10 (24), 25790-25800
DOI 10.1021/acsomega.5c01863, PubMed 40584331
Escherichia coli type I toxin TisB exclusively controls proton depolarization following antibiotic induced DNA damage
Sci Rep, 15 (1), 12774
DOI 10.1038/s41598-025-96136-x, PubMed 40229382
Integrating Docking, Dynamics, and Assays to Predict Antimicrobial Peptide Interactions with Mycolic Acid Membranes in Mycobacterium tuberculosis
ACS Meas Sci Au, 5 (6), 981-1000
DOI 10.1021/acsmeasuresciau.5c00126, PubMed 41425329
Rational design of synthetic antimicrobial peptides based on the Escherichia coli ShoB toxin
Sci Rep, 15 (1), 14354
DOI 10.1038/s41598-025-98330-3, PubMed 40274891
RecN and RecA orchestrate an ordered DNA supercompaction response following ciprofloxacin-induced DNA damage in Escherichia coli
Nucleic Acids Res, 53 (10)
DOI 10.1093/nar/gkaf437, PubMed 40433982
Publications 2023
Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
Int J Mol Sci, 24 (3)
DOI 10.3390/ijms24032914, PubMed 36769243
Survival of Escherichia coli after high-antibiotic stress is dependent on both the pregrown physiological state and incubation conditions
Front Microbiol, 14, 1149978
DOI 10.3389/fmicb.2023.1149978, PubMed 36970700
Publications 2021
Antimicrobial resistance: A challenge awaiting the post-COVID-19 era
Int J Infect Dis, 111, 322-325
DOI 10.1016/j.ijid.2021.09.003, PubMed 34508864
Publications 2020
Antibiotic-induced DNA damage results in a controlled loss of pH homeostasis and genome instability
Sci Rep, 10 (1), 19422
DOI 10.1038/s41598-020-76426-2, PubMed 33173044
Publications 2016
Mutually exclusive RNA secondary structures regulate translation initiation of DinQ in Escherichia coli
RNA, 22 (11), 1739-1749
DOI 10.1261/rna.058461.116, PubMed 27651528
Publications 2014
Development of DinQ from Escherichia coli as an anti-cell-envelope antibiotic
Int J Antimicrob Agents, 45 (2), 196-7
DOI 10.1016/j.ijantimicag.2014.10.005, PubMed 25465525
Publications 2013
Tiling array study of MNNG treated Escherichia coli reveals a widespread transcriptional response
Sci Rep, 3, 3053
DOI 10.1038/srep03053, PubMed 24157950
Single transmembrane peptide DinQ modulates membrane-dependent activities
PLoS Genet, 9 (2), e1003260
DOI 10.1371/journal.pgen.1003260, PubMed 23408903
Publications 2010
Tiling array analysis of UV treated Escherichia coli predicts novel differentially expressed small peptides
PLoS One, 5 (12), e15356
DOI 10.1371/journal.pone.0015356, PubMed 21203457
Publications 2008
Cellular responses to targeted genomic sequence modification using single-stranded oligonucleotides and zinc-finger nucleases
DNA Repair (Amst), 8 (3), 298-308
DOI 10.1016/j.dnarep.2008.11.011, PubMed 19071233